Crestline Management

Latest statistics and disclosures from Crestline Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are DNLI, SANA, EGHT, and represent 100.00% of Crestline Management's stock portfolio.
  • Added to shares of these 1 stock: EGHT.
  • Reduced shares in these 2 stocks: DNLI (-$12M), SANA.
  • Crestline Management was a net seller of stock by $-13M.
  • Crestline Management has $46M in assets under management (AUM), dropping by -13.24%.
  • Central Index Key (CIK): 0001536054

Tip: Access up to 7 years of quarterly data

Positions held by Crestline Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Crestline Management

Crestline Management holds 3 positions in its portfolio as reported in the March 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Denali Therapeutics (DNLI) 91.7 $42M -21% 2.2M 19.20
 View chart
Sana Biotechnology (SANA) 4.7 $2.2M -38% 756k 2.88
 View chart
8x8 (EGHT) 3.6 $1.6M 991k 1.66
 View chart

Past Filings by Crestline Management

SEC 13F filings are viewable for Crestline Management going back to 2011

View all past filings